E76.22 Sanfilippo mucopolysaccharidoses

Name of the Condition

• Sanfilippo mucopolysaccharidoses (ICD-10 Code: E76.22)

Summary

Sanfilippo mucopolysaccharidoses are a rare inherited disorder characterized by the accumulation of glycosaminoglycans (GAGs) due to enzyme deficiencies. This buildup disrupts normal cellular function, leading to progressive multisystem involvement, including skeletal abnormalities, organ enlargement, and neurological impairment. Early recognition and management are important to address complications and slow disease progression.

Causes

The disorder is caused by genetic mutations that impair enzymes responsible for breaking down glycosaminoglycans. These mutations result in the accumulation of undegraded GAGs in cells, tissues, and organs, disrupting normal structure and function. The specific enzyme deficiency determines the type and severity of the condition.

Risk Factors

• Family history of mucopolysaccharidoses or related lysosomal storage disorders.
• Consanguineous relationships (increased risk of recessive inheritance).
• Ethnic or geographic populations with higher carrier rates for specific mutations.

Symptoms

• Skeletal abnormalities, such as short stature, joint stiffness, or dysostosis multiplex.
• Organ enlargement (e.g., hepatosplenomegaly).
• Neurological symptoms, including developmental delay, seizures, or cognitive impairment.
• Coarse facial features.

Diagnosis

Diagnosis typically involves clinical evaluation, biochemical testing to measure enzyme activity, and genetic testing to identify specific mutations. Urine tests may detect elevated GAG levels, and imaging studies can assess organ and skeletal involvement.

Treatment Options

Treatment focuses on managing symptoms and complications, as there is no cure. Options may include enzyme replacement therapy, hematopoietic stem cell transplantation, and supportive care for neurological, respiratory, or cardiac issues.

Prognosis and Follow-Up

Prognosis varies by subtype but is generally poor due to progressive neurological decline. Regular follow-up with specialists is essential to monitor organ function, developmental milestones, and quality of life.

Complications

• Severe neurological impairment, including loss of motor skills and cognitive function.
• Respiratory complications from airway obstruction or restrictive lung disease.
• Cardiac issues, such as valve abnormalities or cardiomyopathy.
• Vision or hearing loss.

Lifestyle & Prevention

• Genetic counseling for families with a history of the disorder.
• Early intervention services to support developmental needs.
• Regular monitoring of organ function and neurological status.

When to Seek Professional Help

Seek medical attention if symptoms of developmental delay, organ enlargement, or skeletal abnormalities appear, especially in children with a family history of lysosomal storage disorders.

Tips for Medical Coders

Document the specific subtype of Sanfilippo mucopolysaccharidoses when available, as this may impact coding specificity. Ensure clinical documentation supports the diagnosis and any associated complications to justify code assignment.